Abstract
Gene-environment associations are important in rheumatoid arthritis (RA) susceptibility, with an association existing between smoking, HLA- DRB1 'shared epitope' alleles, PTPN22 and antibodies to cyclic citrullinated peptides(CCP)1,2. Here, we test the hypothesis that a subset of the anti-CCP response, with specific autoimmunity to citrullinated α-enolase3,4, accounts for an important portion of these associations. In 1,497 individuals from three RA cohorts, antibodies to the immunodominant citrullinated α-enolase CEP-1 epitope4 were detected in 43–63% of the anti-CCP–positive individuals, and this subset was preferentially linked to HLA-DRB1*04. In a case-control analysis of 1,000 affected individuals and 872 controls, the combined effect of shared epitope, PTPN22 and smoking showed the strongest association with the anti-CEP-1–positive subset (odds ratio (OR) of 37, compared to an OR of 2 for the corresponding anti-CEP-1–negative, anti-CCP–positive subset). We conclude that citrullinated α-enolase is a specific citrullinated autoantigen that links smoking to genetic risk factors in the development of RA.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Change history
26 November 2009
In the version of this article initially published, the x–axes of Figure 4 panels A–C were incorrectly labeled. The error has been corrected in the HTML and PDF versions of the article.
References
Klareskog, L. et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 54, 38–46 (2006).
Huizinga, T.W. et al. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum. 52, 3433–3438 (2005).
Kinloch, A. et al. Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res. Ther. 7, R1421–R1429 (2005).
Lundberg, K. et al. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum. 58, 3009–3019 (2008).
Gregersen, P.K., Silver, J. & Winchester, R.J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30, 1205–1213 (1987).
Silman, A.J., Newman, J. & MacGregor, A.J. Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins. Arthritis Rheum. 39, 732–735 (1996).
Makrygiannakis, D. et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann. Rheum Dis. 67, 1488–1492 (2008).
Klareskog, L., Ronnelid, J., Lundberg, K., Padyukov, L. & Alfredsson, L. Immunity to citrullinated proteins in rheumatoid arthritis. Annu. Rev. Immunol. 26, 651–675 (2008).
Schellekens, G.A. et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 43, 155–163 (2000).
van Venrooij, W.J., Hazes, J.M. & Visser, H. Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth. J. Med. 60, 383–388 (2002).
Terrier, B. et al. Alpha-enolase: a target of antibodies in infectious and autoimmune diseases. Autoimmun. Rev. 6, 176–182 (2007).
Kinloch, A. et al. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. Arthritis Rheum. 58, 2287–2295 (2008).
Saulot, V. et al. Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis. Arthritis Rheum. 46, 1196–1201 (2002).
Snir, O. et al. Antibodies towards several citrullinated antigens are enriched in the joints of RA patients. Arthritis Rheum. (2009)(in the press).
Stolt, P. et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann. Rheum. Dis. 62, 835–841 (2003).
Hay, E.M., Ollier, W.E. & Silman, A.J. The Arthritis and Rheumatism Council's national family material repository. Br. J. Rheumatol. 32, 443–444 (1993).
Symmons, D.P. & Silman, A.J. The Norfolk Arthritis Register (NOAR). Clin. Exp. Rheumatol. 21, S94–S99 (2003).
van der Helm-van Mil, A.H. et al. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum. 54, 1117–1121 (2006).
Zanelli, E., Breedveld, F.C. & de Vries, R.R. HLA class II association with rheumatoid arthritis: facts and interpretations. Hum. Immunol. 61, 1254–1261 (2000).
Snir, O. et al. Multiple antibody reactivities to citrullinated antigens in sera from rheumatoid arthritis patients-association with HLA-DRB1 alleles. Ann. Rheum. Dis. 68, 736–743 (2008).
Rothman, K.J., Greenland, S. & Walker, A.M. Concepts of interaction. Am. J. Epidemiol. 112, 467–470 (1980).
Hosmer, D.W. & Lemeshow, S. Confidence interval estimation of interaction. Epidemiology 3, 452–456 (1992).
Begovich, A.B. et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75, 330–337 (2004).
Kallberg, H. et al. Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am. J. Hum. Genet. 80, 867–875 (2007).
Ding, B. et al. Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region. Arthritis Rheum. 60, 30–38 (2009).
Peng, J. et al. Brd2 is a TBP-associated protein and recruits TBP into E2F–1 transcriptional complex in response to serum stimulation. Mol. Cell. Biochem. 294, 45–54 (2007).
Matsumoto, I., Staub, A., Benoist, C. & Mathis, D. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 286, 1732–1735 (1999).
Matsumoto, I. et al. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat. Immunol. 3, 360–365 (2002).
Arnett, F.C. et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31, 315–324 (1988).
Harrison, B. et al. The influence of HLA-DRB1 alleles and rheumatoid factor on disease outcome in an inception cohort of patients with early inflammatory arthritis. Arthritis Rheum. 42, 2174–2183 (1999).
Plenge, R.M. et al. Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am. J. Hum. Genet. 77, 1044–1060 (2005).
Andersson, T., Alfredsson, L., Kallberg, H., Zdravkovic, S. & Ahlbom, A. Calculating measures of biological interaction. Eur. J. Epidemiol. 20, 575–579 (2005).
Källberg, H., Ahlbom, A. & Alfredsson, L. Calculating measures of biological interaction using R. Eur. J. Epidemiol. 21, 571–573 (2006).
Miettinen, O. Estimability and estimation in case-referent studies. Am. J. Epidemiol. 103, 226–235 (1976).
Acknowledgements
The authors wish to acknowledge M. Andersson, M. Mullazhi and M. Widhe for their input regarding the development of the anti-CEP-1 ELISA. We would also like to thank investigators and study participants from the EIRA, the NR and the NOAR studies for their contributions. This work was supported by grants from the Arthritis Research Campaign, the Swedish Research Council, the Swedish Council for Working Life and Social Research, the Arbetsmarknadens Försäkrings Aktibebolag insurance foundation, the US National Institutes of Health (grant P60 AR047782), FAMRI (Flight Attendants Medical Research Institute), the Swedish Rheumatism Association, King Gustav V's 80-year foundation and the Swedish Fund for Research Without Animal Experiments. This study is part of the EU funded research project AutoCure, within the sixth framework program.
Author information
Authors and Affiliations
Contributions
H.M. performed ELISA assays on EIRA, performed statistical analyses and produced the figures. B.F. performed ELISA assays on NR and NOAR, performed statistical analyses and contributed to writing of the paper. H.K. performed statistical analyses on EIRA, produced the tables and contributed to the writing of the Supplementary Note and Methods sections. D.P. performed statistical analyses and HLA-DRB1 genotyping on NR and NOAR. V.M. supervised laboratory experiments and supervised statistical analysis on EIRA. J.R. developed the CEP-1 ELISA. P.C. supervised laboratory experiments on NR and NOAR. B.D. performed the SNP analyses. L.A. supervised statistical analyses on EIRA and wrote the Supplementary Note and Methods section on interaction analyses. L.P. performed the HLA-DRB1 and PTPN22 genotyping on EIRA. D.P.M.S. is responsible for the NOAR study and supervised statistical analyses on NR and NOAR. P.J.V. designed the study and supervised laboratory experiments on NR and NOAR. L.K. is responsible for the EIRA study and the design of the study. K.L. performed ELISA assays on NR and NOAR, designed the study and wrote the paper. All authors contributed to the final paper.
Corresponding author
Ethics declarations
Competing interests
A patent for the diagnostic use of the CEP-1 peptide (patent application number: WO0890360, published on 31 July 2008) is jointly held by two of the authors (P.J.V. and K.L.) and funded by Imperial Innovations, Imperial College London.
Supplementary information
Supplementary Text and Figures
Supplementary Tables 1–3 and Supplementary Note (PDF 331 kb)
Rights and permissions
About this article
Cite this article
Mahdi, H., Fisher, B., Källberg, H. et al. Specific interaction between genotype, smoking and autoimmunity to citrullinated α-enolase in the etiology of rheumatoid arthritis. Nat Genet 41, 1319–1324 (2009). https://doi.org/10.1038/ng.480
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.480
This article is cited by
-
From risk to chronicity: evolution of autoreactive B cell and antibody responses in rheumatoid arthritis
Nature Reviews Rheumatology (2022)
-
Destructive Roles of Fibroblast-like Synoviocytes in Chronic Inflammation and Joint Damage in Rheumatoid Arthritis
Inflammation (2021)
-
Heritability of skewed X-inactivation in female twins is tissue-specific and associated with age
Nature Communications (2019)
-
Autoantibody and metalloproteinase activity in early arthritis
Clinical Rheumatology (2019)
-
Smoking under hypoxic conditions: a potent environmental risk factor for inflammatory and autoimmune diseases
Military Medical Research (2018)